Q4 2024 Earnings Call Transcript March 20, 2025 Cibus, Inc. misses on earnings expectations. Reported EPS is $-0.87 EPS, ...

Founder, Chief Operating Officer, Director, Interim Chief Executive Officer; Cibus Inc Greg Gocal; Co-Founder, Executive Vice President, Chief Scientific Officer; Cibus Inc Laurence Alexander; Analyst ...

Advances in the gene-editing technology known as CRISPR-Cas9 over the past 15 years have yielded important new insights into the roles that specific genes play in many diseases. But to date this ...

A pair of privately-held developers of editing-based therapies have some successes to show for their recent efforts to ...

EU countries have officially sealed their position on plans to loosen rules on the use of new genetic technologies, setting ...

A research team has uncovered new insights into the molecular mechanisms of ADAR1, a protein that regulates ribonucleic acid (RNA) induced immune responses. Their findings could open new pathways for ...

Advancements in genome editing, particularly CRISPR, are reshaping precision biology, driving innovations in medicine, agriculture, and synthetic biology.

Legislation aims to adapt EU law to reflect scientific and technological progress, enabling the products of New Genomic Techniques (NGTs), such ...

Currently, these technologies are subject to the EU’s strict GMO regulation, making their commercialisation in the bloc ...

Researchers are using gene editing techniques to introduce beneficial traits like polled and disease resistance, as well as ...